Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Acute Pancreatitis | Research

Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis

Authors: Ji-Hao Xu, Chu-Yan Ni, Yan-Yan Zhuang, Li Li, Ying Lin, Zhong-Sheng Xia, Wei-Rong Wu, Qi-Kui Chen, Wa Zhong

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Intraductal papillary mucinous neoplasm (IPMN) is a cystic tumor of the pancreas arising from abnormal papillary proliferation of ductal epithelial cells, and is a precancerous lesion of pancreatic malignancy. This study aimed to evaluate associations between acute pancreatitis (AP) and histologic subtypes of IPMN.

Methods

In the clinical study, patients with IPMN confirmed by surgical resection specimens at our institute between 2009 and 2021 were eligible for inclusion. Associations and predictive accuracy of AP on the presence of HGD were determined by logistic regressions. In addition, a systematic review and meta-analysis was conducted through literatures upon search in PubMed, Embase, CENTRAL, China National Knowledge Infrastructure (CKNI), and Wanfang database, up to June, 2023. Pooled effects of the associations between AP and HGD and intestinal epithelial subtype subtype, shown as odds ratios (ORs) with 95% confidence intervals (CIs), were calculated using random effects model.

Results

The retrospective cohort study included 47 patients (32 males, 15 females) diagnosed with IPMN at our center between 2009 and 2021, including 11 cases with AP (median 62 years) and 36 cases (median 64.5 years) without. Accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of AP in predicting HGD were 78.7%, 57.1%, 82.5%, 36.4%, and 91.7%, respectively. Univariate logistic regression analysis showed that AP group had greater odds of presence of HGD (OR: 6.29,95% CI: 1.14–34.57) than non-AP group. Meta-analysis of five case-control studies in the literature included 930 patients and showed that AP-IPMN patients had higher odds for HGD (OR: 2.13, 95% CI 1.38–3.29) and intestinal epithelial subtype (OR: 5.38, 95% CI: 3.50–8.27) compared to non-AP IPMN.

Conclusions

AP is predictive of malignancy in patients with IPMN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Del Chiaro M, Verbeke C. Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features. Histopathology. 2017;70(6):850–60.CrossRefPubMed Del Chiaro M, Verbeke C. Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features. Histopathology. 2017;70(6):850–60.CrossRefPubMed
2.
go back to reference Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management. Scand J Gastroenterol. 2017;52(8):803–15.CrossRefPubMed Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management. Scand J Gastroenterol. 2017;52(8):803–15.CrossRefPubMed
3.
go back to reference Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.CrossRefPubMed Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.CrossRefPubMed
4.
go back to reference Bosman FTCF, Hruban RH. WHO classification of tumours of the digestive system. Volume 3, 4th ed. Lyon: International Agency for Research on Cancer; 2010. Bosman FTCF, Hruban RH. WHO classification of tumours of the digestive system. Volume 3, 4th ed. Lyon: International Agency for Research on Cancer; 2010.
5.
go back to reference Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447(5):794–9.CrossRefPubMed Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447(5):794–9.CrossRefPubMed
6.
go back to reference Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, et al. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2013;13(6):583–8.CrossRefPubMed Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, et al. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2013;13(6):583–8.CrossRefPubMed
7.
go back to reference Koh YX, Zheng HL, Chok AY, Tan CS, Wyone W, Lim TK, et al. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms. Surgery. 2015;157(3):496–509.CrossRefPubMed Koh YX, Zheng HL, Chok AY, Tan CS, Wyone W, Lim TK, et al. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms. Surgery. 2015;157(3):496–509.CrossRefPubMed
8.
go back to reference Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006;30(12):1561–9.CrossRefPubMed Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006;30(12):1561–9.CrossRefPubMed
9.
go back to reference Heckler M, Brieger L, Heger U, Pausch T, Tjaden C, Kaiser J, et al. Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas. BJS Open. 2018;2(1):13–24.CrossRefPubMedPubMedCentral Heckler M, Brieger L, Heger U, Pausch T, Tjaden C, Kaiser J, et al. Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas. BJS Open. 2018;2(1):13–24.CrossRefPubMedPubMedCentral
10.
go back to reference Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15.CrossRefPubMed Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15.CrossRefPubMed
11.
go back to reference Coyle WJ, Pineau BC, Tarnasky PR, Knapple WL, Aabakken L, Hoffman BJ, et al. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. Endoscopy. 2002;34(8):617–23.CrossRefPubMed Coyle WJ, Pineau BC, Tarnasky PR, Knapple WL, Aabakken L, Hoffman BJ, et al. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. Endoscopy. 2002;34(8):617–23.CrossRefPubMed
12.
go back to reference Mujica VR, Barkin JS, Go VL. Acute pancreatitis secondary to pancreatic carcinoma. Study Group Participants Pancreas. 2000;21(4):329–32. Mujica VR, Barkin JS, Go VL. Acute pancreatitis secondary to pancreatic carcinoma. Study Group Participants Pancreas. 2000;21(4):329–32.
13.
go back to reference Venkatesh PG, Navaneethan U, Vege SS. Intraductal papillary mucinous neoplasm and acute pancreatitis. J Clin Gastroenterol. 2011;45(9):755–8.CrossRefPubMed Venkatesh PG, Navaneethan U, Vege SS. Intraductal papillary mucinous neoplasm and acute pancreatitis. J Clin Gastroenterol. 2011;45(9):755–8.CrossRefPubMed
14.
go back to reference Jang JW, Kim MH, Jeong SU, Kim J, Park DH, Lee SS, et al. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J Gastroenterol Hepatol. 2013;28(4):731–8.CrossRefPubMed Jang JW, Kim MH, Jeong SU, Kim J, Park DH, Lee SS, et al. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J Gastroenterol Hepatol. 2013;28(4):731–8.CrossRefPubMed
15.
go back to reference Hata T, Sakata N, Okada T, Aoki T, Motoi F, Katayose Y, et al. Dilated papilla with mucin extrusion is a potential predictor of acute pancreatitis associated with intraductal papillary mucinous neoplasms of pancreas. Pancreatology. 2013;13(6):615–20.CrossRefPubMed Hata T, Sakata N, Okada T, Aoki T, Motoi F, Katayose Y, et al. Dilated papilla with mucin extrusion is a potential predictor of acute pancreatitis associated with intraductal papillary mucinous neoplasms of pancreas. Pancreatology. 2013;13(6):615–20.CrossRefPubMed
16.
go back to reference Pelletier AL, Hammel P, Rebours V, Couvelard A, Vullierme MP, Maire F, et al. Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and clinicopathologic correlations. Pancreas. 2010;39(5):658–61.CrossRefPubMed Pelletier AL, Hammel P, Rebours V, Couvelard A, Vullierme MP, Maire F, et al. Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and clinicopathologic correlations. Pancreas. 2010;39(5):658–61.CrossRefPubMed
17.
go back to reference Tsutsumi K, Ohtsuka T, Oda Y, Sadakari Y, Mori Y, Aishima S, et al. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology. 2010;10(6):707–12.CrossRefPubMed Tsutsumi K, Ohtsuka T, Oda Y, Sadakari Y, Mori Y, Aishima S, et al. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology. 2010;10(6):707–12.CrossRefPubMed
18.
go back to reference Shin SH, Han DJ, Park KT, Kim YH, Park JB, Kim SC. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2010;34(4):776–83.CrossRefPubMed Shin SH, Han DJ, Park KT, Kim YH, Park JB, Kim SC. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2010;34(4):776–83.CrossRefPubMed
19.
go back to reference Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Gonzalez-Gonzalez LA, Warshaw AL, Lillemoe KD, et al. Acute pancreatitis in intraductal papillary mucinous neoplasms: a common predictor of malignant intestinal subtype. Surgery. 2015;158(5):1219–25.CrossRefPubMed Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Gonzalez-Gonzalez LA, Warshaw AL, Lillemoe KD, et al. Acute pancreatitis in intraductal papillary mucinous neoplasms: a common predictor of malignant intestinal subtype. Surgery. 2015;158(5):1219–25.CrossRefPubMed
20.
go back to reference Hwang JA, Choi SY, Lee JE, Kim SS, Lee S, Moon JY, et al. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline. Eur Radiol. 2020;30(7):3711–22.CrossRefPubMed Hwang JA, Choi SY, Lee JE, Kim SS, Lee S, Moon JY, et al. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline. Eur Radiol. 2020;30(7):3711–22.CrossRefPubMed
21.
go back to reference Tanaka T, Masuda A, Sofue K, Toyama H, Shiomi H, Sakai A, et al. Acute pancreatitis in intraductal papillary mucinous neoplasms correlates with pancreatic volume and epithelial subtypes. Pancreatology. 2021;21(1):138–43.CrossRefPubMed Tanaka T, Masuda A, Sofue K, Toyama H, Shiomi H, Sakai A, et al. Acute pancreatitis in intraductal papillary mucinous neoplasms correlates with pancreatic volume and epithelial subtypes. Pancreatology. 2021;21(1):138–43.CrossRefPubMed
22.
go back to reference Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRefPubMed Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRefPubMed
23.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583.CrossRefPubMedPubMedCentral Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583.CrossRefPubMedPubMedCentral
24.
go back to reference Kosmahl M, Pauser U, Peters K, Sipos B, Lüttges J, Kremer B, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004;445(2):168–78.CrossRefPubMed Kosmahl M, Pauser U, Peters K, Sipos B, Lüttges J, Kremer B, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004;445(2):168–78.CrossRefPubMed
25.
go back to reference Kirkegård J, Cronin-Fenton D, Heide-Jørgensen U, Mortensen FV. Acute Pancreatitis and Pancreatic Cancer risk: a Nationwide Matched-Cohort Study in Denmark. Gastroenterology. 2018;154(6):1729–36.CrossRefPubMed Kirkegård J, Cronin-Fenton D, Heide-Jørgensen U, Mortensen FV. Acute Pancreatitis and Pancreatic Cancer risk: a Nationwide Matched-Cohort Study in Denmark. Gastroenterology. 2018;154(6):1729–36.CrossRefPubMed
26.
go back to reference Roch AM, Parikh JA, Al-Haddad MA, DeWitt JM, Ceppa EP, House MG, et al. Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms. Surgery. 2014;156(4):923–9.CrossRefPubMed Roch AM, Parikh JA, Al-Haddad MA, DeWitt JM, Ceppa EP, House MG, et al. Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms. Surgery. 2014;156(4):923–9.CrossRefPubMed
27.
go back to reference Tanaka M, Kobayashi K, Mizumoto K, Yamaguchi K. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2005;40(7):669–75.CrossRefPubMed Tanaka M, Kobayashi K, Mizumoto K, Yamaguchi K. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2005;40(7):669–75.CrossRefPubMed
28.
go back to reference Engjom T, Nordaas IK, Tjora E, Dimcevski G, Haldorsen IS, Olesen SS, et al. Aetiological risk factors are associated with distinct imaging findings in patients with chronic pancreatitis: a study of 959 cases from the Scandinavian Baltic Pancreatic Club (SBPC) imaging database. Pancreatology. 2021;21(4):688–97.CrossRefPubMed Engjom T, Nordaas IK, Tjora E, Dimcevski G, Haldorsen IS, Olesen SS, et al. Aetiological risk factors are associated with distinct imaging findings in patients with chronic pancreatitis: a study of 959 cases from the Scandinavian Baltic Pancreatic Club (SBPC) imaging database. Pancreatology. 2021;21(4):688–97.CrossRefPubMed
30.
go back to reference Shahid RA, Vigna SR, Huang MN, Gunn MD, Liddle RA. Nicotinic stimulation of splenic T cells is protective in endoscopic retrograde cholangiopancreatography-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2022;323(5):G420–g7.CrossRefPubMedPubMedCentral Shahid RA, Vigna SR, Huang MN, Gunn MD, Liddle RA. Nicotinic stimulation of splenic T cells is protective in endoscopic retrograde cholangiopancreatography-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2022;323(5):G420–g7.CrossRefPubMedPubMedCentral
Metadata
Title
Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis
Authors
Ji-Hao Xu
Chu-Yan Ni
Yan-Yan Zhuang
Li Li
Ying Lin
Zhong-Sheng Xia
Wei-Rong Wu
Qi-Kui Chen
Wa Zhong
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02972-4

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.